The Balancing Act® Takes the Show on the Road with American Honda
April 4, 2016
FOR IMMEDIATE RELEASE
(DEERFIELD BEACH, Fla. – PR LOG – April 4, 2016) The Balancing Act® welcomes the experts on motorcycles for every rider, Tuesday, April 5 and April 12, 2016 at 7:30 a.m. (ET/PT) on Lifetime®.
Don’t miss this special guest on The Balancing Act:
Encouraging Women to Ride – with American Honda
Despite their macho image, motorcycles are no longer just for men. The Balancing Act’s resident adventure woman, Rachel Leigh, and nine-time Motocross Champion, Mercedes Gonzalez-Natvig, suit up to show women what they’ve been missing. Learn all about bike safety, how to get your license for on-road riding, and how to plan that off-road adventure with the entire family. Thanks to American Honda, there’s a bike for every skill level, price range and rider – boy or girl. Go to www.powersports.honda.com to see all of their available models.
About The Balancing Act®
Entering its 8th season, The Balancing Act continues to empower women in all aspects of their lives. The mission at The Balancing Act is simple – to help today’s modern woman balance it all by bringing them positive solutions to enrich and empower them. Entertaining, educational and trusted by women, viewers can tune in to America’s premier morning show on weekday mornings at 7:30 am (ET/PT) on Lifetime television. For additional information or to view a segment visit: www.thebalancingact.com.
Join the Conversation!
Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]
iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.
There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.